Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
2022 · New England Journal of Medicine · 2,396 citations
https://doi.org/10.1056/nejmoa2203690
Y
Yibin Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.0K
Papers
41.5K
Citations
99
h-index
414
i10-index
Yibin Wang is an academic researcher from Shihezi University. The author has contributed to research in topics: Mitochondrial Function and Pathology & Cardiac Fibrosis and Remodeling & Signaling Pathways in Disease. The author has an h-index of 99, co-authored 865 publications.
ORCID: 0000-0003-0852-0767Papers by this author
worksThe global burden of metabolic disease: Data from 2000 to 2019
2023 · Cell Metabolism · 703 citations
https://doi.org/10.1016/j.cmet.2023.02.003
Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway
2020 · Nature Communications · 191 citations
https://doi.org/10.1038/s41467-019-13911-x
The Hybrid Mouse Diversity Panel: a resource for systems genetics analyses of metabolic and cardiovascular traits
2016 · Journal of Lipid Research · 169 citations
https://doi.org/10.1194/jlr.r066944
A Fast Workflow for Identification and Quantification of Proteomes
2013 · Molecular & Cellular Proteomics · 114 citations
https://doi.org/10.1074/mcp.o112.025023
MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
2020 · Journal of Molecular and Cellular Cardiology · 106 citations
https://doi.org/10.1016/j.yjmcc.2020.08.017
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat